⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001395027

Sinclair David

Reports to the SEC for 2 companies · NEW YORK, NY

Transactions

8

Companies

2

Filings

3

CIK

0001395027

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2008-01-02	Sirtris Pharmaceuticals, Inc.Non-Qualified Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2008-01-02	Sirtris Pharmaceuticals, Inc.A Award	Director	AAward	+20K sh	—	—	182,834
2008-01-02	Sirtris Pharmaceuticals, Inc.Non-Qualified Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2008-01-02	Sirtris Pharmaceuticals, Inc.A Award	Director	AAward	+20K sh	—	—	182,834
2007-05-29	Sirtris Pharmaceuticals, Inc.C Conversion	Director	CConversion	+9,524 sh	—	—	160,000
2007-05-29	Sirtris Pharmaceuticals, Inc.C Conversion	Director	CConversion	+2,834 sh	—	—	162,834
2007-05-29	Sirtris Pharmaceuticals, Inc.Series A Redeemable Convertible Preferred StockC Conversion	Director	CConversion	−50K sh	—	—	0
2007-05-29	Sirtris Pharmaceuticals, Inc.Sereis C-1 Redeemable Convertible Preferred StockC Conversion	Director	CConversion	−14.9K sh	—	—	0

Recent filings

3

Accepted (ET)
Jan 224/A
Sirtris Pharmaceuticals, Inc.0001179110-08-001473
SEC(opens sec.gov)
Jan 44/A
Sirtris Pharmaceuticals, Inc.0001179110-08-000567
SEC(opens sec.gov)
May 314
Sirtris Pharmaceuticals, Inc.0001179110-07-011775
SEC(opens sec.gov)

Companies

2

Address

C/O FRONTIER ACQUISITION CORP. 660 MADISON AVENUE, 19TH FLOOR

NEW YORK, NY, 10065